198 related articles for article (PubMed ID: 34282210)
1. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.
López-Hernández Y; Monárrez-Espino J; Oostdam AH; Delgado JEC; Zhang L; Zheng J; Valdez JJO; Mandal R; González FLO; Moreno JCB; Trejo-Medinilla FM; López JA; Moreno JAE; Wishart DS
Sci Rep; 2021 Jul; 11(1):14732. PubMed ID: 34282210
[TBL] [Abstract][Full Text] [Related]
2. Immunometabolic signatures predict risk of progression to sepsis in COVID-19.
Herrera-Van Oostdam AS; Castañeda-Delgado JE; Oropeza-Valdez JJ; Borrego JC; Monárrez-Espino J; Zheng J; Mandal R; Zhang L; Soto-Guzmán E; Fernández-Ruiz JC; Ochoa-González F; Trejo Medinilla FM; López JA; Wishart DS; Enciso-Moreno JA; López-Hernández Y
PLoS One; 2021; 16(8):e0256784. PubMed ID: 34460840
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
Ramesh J; Reddy SLS; Rajesh M; Varghese J
Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
[TBL] [Abstract][Full Text] [Related]
4. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
5. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.
Roberts I; Wright Muelas M; Taylor JM; Davison AS; Xu Y; Grixti JM; Gotts N; Sorokin A; Goodacre R; Kell DB
Metabolomics; 2021 Dec; 18(1):6. PubMed ID: 34928464
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019.
Santotoribio JD; Nuñez-Jurado D; Lepe-Balsalobre E
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902237
[TBL] [Abstract][Full Text] [Related]
7. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
D'Amora P; Silva IDCG; Budib MA; Ayache R; Silva RMS; Silva FC; Appel RM; Júnior SS; Pontes HBD; Alvarenga AC; Arima EC; Martins WG; Silva NLF; Diaz RS; Salzgeber MB; Palma AM; Evans SS; Nagourney RA
PLoS One; 2021; 16(12):e0259909. PubMed ID: 34851990
[TBL] [Abstract][Full Text] [Related]
8. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.
Ducastel M; Chenevier-Gobeaux C; Ballaa Y; Meritet JF; Brack M; Chapuis N; Pene F; Carlier N; Szwebel TA; Roche N; Terrier B; Borderie D
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299080
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
Marín-Corral J; Rodríguez-Morató J; Gomez-Gomez A; Pascual-Guardia S; Muñoz-Bermúdez R; Salazar-Degracia A; Pérez-Terán P; Restrepo MI; Khymenets O; Haro N; Masclans JR; Pozo OJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946479
[TBL] [Abstract][Full Text] [Related]
10. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
[TBL] [Abstract][Full Text] [Related]
11. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19.
Poudel A; Poudel Y; Adhikari A; Aryal BB; Dangol D; Bajracharya T; Maharjan A; Gautam R
PLoS One; 2021; 16(8):e0256744. PubMed ID: 34437642
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. Could Soluble Endothelial Protein C Receptor Levels Recognize SARS-CoV2-Positive Patients Requiring Hospitalization?
Vassiliou AG; Keskinidou C; Jahaj E; Gallos P; Zacharis A; Athanasiou N; Tsipilis S; Mastora Z; Dimopoulou I; Kotanidou A; Orfanos SE
Shock; 2021 Nov; 56(5):733-736. PubMed ID: 33756504
[TBL] [Abstract][Full Text] [Related]
14. Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study.
Arnold DT; Attwood M; Barratt S; Morley A; Elvers KT; McKernon J; Donald C; Oates A; Noel A; MacGowan A; Maskell NA; Hamilton FW
Emerg Med J; 2021 Jul; 38(7):543-548. PubMed ID: 34021028
[TBL] [Abstract][Full Text] [Related]
15. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
16. Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19.
Wongvibulsin S; Garibaldi BT; Antar AAR; Wen J; Wang MC; Gupta A; Bollinger R; Xu Y; Wang K; Betz JF; Muschelli J; Bandeen-Roche K; Zeger SL; Robinson ML
Ann Intern Med; 2021 Jun; 174(6):777-785. PubMed ID: 33646849
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of COVID-19 Metabolomics Identifies Variations in Robustness of Biomarkers.
Onoja A; von Gerichten J; Lewis HM; Bailey MJ; Skene DJ; Geifman N; Spick M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762673
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Leucocyte to High-Density Lipoprotein-Cholesterol Ratios in COVID-19 Patients and the Diabetes Subgroup.
Wang Y; Zhang J; Li H; Kong W; Zheng J; Li Y; Wei Q; Li Q; Yang L; Xu Y; Li L; Wang H; Sun H; Xia W; Liu G; Zhong X; Qiu K; Wang H; Liu H; Song X; Xiong S; Liu Y; Cui Z; Chen L; Zeng T
Front Endocrinol (Lausanne); 2021; 12():727419. PubMed ID: 34589058
[TBL] [Abstract][Full Text] [Related]
20. Plasma metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients.
Soares NC; Hussein A; Muhammad JS; Semreen MH; ElGhazali G; Hamad M
PLoS One; 2023; 18(8):e0289738. PubMed ID: 37561777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
